In this study, no separate effect of BRCA1 mutation status on overall prognosis of TNBC was evaluated, negative ER and PR status was defined as nuclear staining of ≤10% and patients with previous ovarian cancer were included in the study (13). The gene discussed is BRCA1; the disease is ovarian carcinoma.